AI-In Cardiology Market is estimated to increase at a growth rate of 32.8% CAGR over the forecast period from 2024 to 2030.
The AI-In Cardiology Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Component (Hardware, Software Solutions, Services), By Application (Cardiac Arrhythmias, Stroke, Ischemic Heart Disease /CAD, Others).
The AI-In Cardiology market in 2024 represents a transformative approach to cardiovascular medicine, leveraging artificial intelligence (AI) algorithms, machine learning, and big data analytics to enhance risk prediction, diagnosis, and treatment of cardiovascular diseases. AI-based solutions offer advanced capabilities for analyzing cardiac imaging, electrocardiography (ECG), and patient data to identify early signs of heart disease, predict adverse events, and optimize treatment strategies. The market is witnessing rapid adoption of AI-powered diagnostic tools, remote monitoring platforms, and decision support systems by cardiologists, healthcare providers, and medical device manufacturers, driven by the need to address challenges such as rising cardiovascular disease burden, limited access to specialized care, and healthcare disparities. Moreover, advancements in AI algorithms, deep learning architectures, and multimodal data integration are expanding the scope and applications of AI-In cardiology, enabling more accurate risk stratification, personalized interventions, and improved patient outcomes in cardiovascular care.
A prominent trend in the AI-In Cardiology market is the development and adoption of AI-powered decision support systems. These systems leverage machine learning algorithms to analyze cardiac data from various sources, including electrocardiograms (ECGs), echocardiograms, cardiac MRIs, and patient electronic health records. By providing real-time insights and predictive analytics, AI-driven decision support systems assist cardiologists in making accurate diagnoses, predicting cardiovascular events, and optimizing treatment strategies. This trend is reshaping cardiology practice by enhancing diagnostic accuracy, efficiency, and patient outcomes while reducing healthcare costs.
The primary driver fueling the AI-In Cardiology market is the increasing burden of cardiovascular diseases (CVDs) worldwide. CVDs, including heart attacks, stroke, heart failure, and arrhythmias, are among the leading causes of mortality and morbidity globally. With the rising prevalence of risk factors such as hypertension, diabetes, obesity, and aging populations, there is a growing demand for innovative technologies to improve CVD diagnosis, risk stratification, and management. AI-based solutions offer the potential to address these challenges by providing cardiologists with advanced tools for early detection, personalized risk assessment, and optimized treatment planning, thereby improving patient outcomes and reducing the burden on healthcare systems.
An opportunity in the AI-In Cardiology market lies in the development of AI-enabled remote monitoring solutions. Remote monitoring of cardiac patients allows for continuous surveillance of vital signs, ECG rhythms, and other cardiac parameters outside of traditional clinical settings. AI algorithms can analyze streaming data from wearable devices, implantable sensors, and mobile health applications to detect abnormalities, predict cardiac events, and alert healthcare providers to intervene promptly. By leveraging AI-enabled remote monitoring solutions, healthcare organizations can enhance patient engagement, enable proactive management of chronic conditions, and reduce hospital readmissions. This opportunity opens avenues for collaboration between technology companies, medical device manufacturers, and healthcare providers to develop integrated platforms that empower patients and improve cardiovascular care delivery.
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
IDOVEN
Arterys Inc
CardiAI
Cardiologs
Cleerly Inc
DiA Imaging Analysis
RSIP Vision
Ultrasight
Ultromics Ltd
Vista AI
Viz ai
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the AI-In Cardiology Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the AI-In Cardiology Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 AI-In Cardiology Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global AI-In Cardiology Market Size Outlook, $ Million, 2021 to 2030
3.2 AI-In Cardiology Market Outlook by Type, $ Million, 2021 to 2030
3.3 AI-In Cardiology Market Outlook by Product, $ Million, 2021 to 2030
3.4 AI-In Cardiology Market Outlook by Application, $ Million, 2021 to 2030
3.5 AI-In Cardiology Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of AI-In Cardiology Market Industry
4.2 Key Market Trends in AI-In Cardiology Market Industry
4.3 Potential Opportunities in AI-In Cardiology Market Industry
4.4 Key Challenges in AI-In Cardiology Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global AI-In Cardiology Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global AI-In Cardiology Market Outlook By Segments
7.1 AI-In Cardiology Market Outlook by Segments
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
8 North America AI-In Cardiology Market Analysis And Outlook To 2030
8.1 Introduction to North America AI-In Cardiology Markets in 2024
8.2 North America AI-In Cardiology Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America AI-In Cardiology Market size Outlook by Segments, 2021-2030
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
9 Europe AI-In Cardiology Market Analysis And Outlook To 2030
9.1 Introduction to Europe AI-In Cardiology Markets in 2024
9.2 Europe AI-In Cardiology Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe AI-In Cardiology Market Size Outlook By Segments, 2021-2030
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
10 Asia Pacific AI-In Cardiology Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific AI-In Cardiology Markets in 2024
10.2 Asia Pacific AI-In Cardiology Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific AI-In Cardiology Market size Outlook by Segments, 2021-2030
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
11 South America AI-In Cardiology Market Analysis And Outlook To 2030
11.1 Introduction to South America AI-In Cardiology Markets in 2024
11.2 South America AI-In Cardiology Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America AI-In Cardiology Market size Outlook by Segments, 2021-2030
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
12 Middle East And Africa AI-In Cardiology Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa AI-In Cardiology Markets in 2024
12.2 Middle East and Africa AI-In Cardiology Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa AI-In Cardiology Market size Outlook by Segments, 2021-2030
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
IDOVEN
Arterys Inc
CardiAI
Cardiologs
Cleerly Inc
DiA Imaging Analysis
RSIP Vision
Ultrasight
Ultromics Ltd
Vista AI
Viz ai
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Component
Hardware
Software Solutions
Services
By Application
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease /CAD
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global AI-In Cardiology Market is one of the lucrative growth markets, poised to register a 32.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
IDOVEN, Arterys Inc, CardiAI, Cardiologs, Cleerly Inc, DiA Imaging Analysis, RSIP Vision, Ultrasight, Ultromics Ltd, Vista AI, Viz ai
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume